SXTP

60 degrees pharmaceuticals, Inc.

• TipRanks·1d ago

  60 Degrees announces early enrollment of first patient in trial of tafenoquine

• PUBT·1d ago

  60 Degrees Pharma enrolls first patient in tafenoquine babesiosis trial in US Northeast hospitals

• Reuters·1d ago

  60 DEGREES PHARMACEUTICALS ANNOUNCES EARLY ENROLLMENT OF FIRST SEASONAL PATIENT IN CLINICAL TRIAL OF TAFENOQUINE FOR PATIENTS HOSPITALIZED WITH BABESIOSIS

• Dow Jones·5d ago

  60 Degrees Pharm Price Target Cut to $3.70/Share From $4.20 by Ascendiant Capital

• Dow Jones·5d ago

  60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital

• Benzinga·5d ago

  Ascendiant Capital Maintains Buy on 60 Degrees, Lowers Price Target to $3.7

• Reuters·6d ago

  U.S. RESEARCH ROUNDUP-Analog Devices, Intuit, Nvidia

• Reuters·6d ago

  60 DEGREES PHARMACEUTICALS INC <SXTP.O>: H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY

• Dow Jones·05/20 17:13

  60 Degrees Pharm Cut to Neutral From Buy by HC Wainwright & Co.

• Benzinga·05/20 17:03

  HC Wainwright & Co. Downgrades 60 Degrees to Neutral

• TipRanks·05/20 16:00

  H.C. Wainwright downgrades 60 Degrees on ‘untenable’ spending

• TipRanks·05/20 15:55

  60 Degrees Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright

• PUBT·05/19 22:14

  60 Degrees Pharma director Eric Francois files initial beneficial ownership statement

• PUBT·05/18 20:33

  60 Degrees Pharma appoints Eric Francois to board

• Benzinga·05/15 13:29

  60 Degrees Q1 EPS $(1.28) Misses $(0.76) Estimate, Sales $76.377K Miss $435.000K Estimate